Filter posts

Biomedical R&D in the 21st Century

Reflecting back upon my career,  I recognize the importance academic-industry research partnerships played in shaping …

#BIO 2013: Open Innovation and Biopharmaceutical R&D

In these changing times, the concept of Open Innovation is one that we at AstraZeneca …

Natalie Ng wins the International BioGENEius Challenge

Today, Cupertino Junior Natalie Ng won the International BioGENEius Challenge, the premier competition for high …

Getting to Know Women in Bio

We caught up with Women In Bio’s President, Phyllis Dillinger, to learn more about the …

Q & A with Eli Lilly’s Eric Siemers

In October 2012, Eli Lilly and Company released results of its Expedition trials, two Phase …

New Challenges in the Fast Changing Landscape of Bioinformatics

The world of DNA sequencing and bioinformatics has evolved at a staggering pace. In 2009, …

Worldwide Orphan Drug Market to Grow to $127 Billion by 2018

The 2013 Orphan Drug Report from Evaluate, which launched today at the 2013 BIO international …

Finding Biotech in the Silicon Prairie

The Silicon Prairie is about more than technology companies and Internet start-ups. In fact, the …

Expanding Access to Orphan Drugs

At present many orphan diseases do not have any licensed treatments, and for those conditions …

Opening Up Innovation

Open Innovation has become a major theme in the life sciences over the last couple …